$887,540.00
Value $1.29T
BRK.A and HIT stock compared: price, dividend, valuation and results, from SEC filings.
$887,540.00
Value $1.29T
$0.33
Value $18M
Berkshire Hathaway (BRK.A) has a market value of $1.29T and Health In Tech (HIT) $18M. Over the last year, with dividends, BRK.A moved +16.2% and HIT -79.4%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
BRK.A$1.29T
HIT$18M
BRK.A is 70,061 times HIT
Revenue, 12 months
BRK.A$395B
HIT$31M
BRK.A is 12,785 times HIT
Net income, 12 months
BRK.A$77.1B
HIT-$11M
Operating margin
BRK.A–
HIT–
ROIC
BRK.A10.6%
HIT-67.4%
78.0 points apart
P/E
BRK.A16.7
HIT–
Dividend yield
BRK.A0.0%
HIT0.0%
About the same
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
BRK.A+16.2%
HIT-79.4%
| Period | BRK.AWith dividends | HITWith dividends |
|---|---|---|
| 1 year since November 14, 2025 | +16.2%Price +16.2% | -79.4%Price -79.4% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
BRK.ABerkshire HathawayHITHealth In Tech
| Price | $887,540.00 | $0.33 |
|---|---|---|
| Market value | $1.29T | $18M |
| Enterprise value (EV) | $1.04T | $15M |
| P/E | 16.7 | – |
| P/E, 5-year median | – | – |
| P/B | 1.7 | 1.4 |
| EV/EBIT | 10.9 | – |
| Free cash flow yield | 1.8% | – |
| Revenue, 12 months | $395B | $31M |
|---|---|---|
| Net income, 12 months | $77.1B | -$11M |
| Free cash flow, 12 months | $22.8B | – |
| Earnings per share, 12 months | $53,021.62 | -$0.19 |
| Revenue growth, year on year | 0.0% | 71.0% |
| Revenue growth a year, past | +8.6%over 5 years | +31.9%over 2 years |
| EPS growth a year, past | – | +100.0%over 1 years |
| Gross margin | – | 50.5% |
|---|---|---|
| Operating margin | – | – |
| Net margin | 19.5% | -37.1% |
| ROIC | 10.6% | -67.4% |
| ROE | 10.5% | -64.9% |
| Cash | $378B | $10M |
|---|---|---|
| Total debt | $131B | $6.7M |
| Net debt / EBITDA | -2.3 | – |
| Interest cover | 18.1× | – |
| Dividend yield | – | – |
|---|---|---|
| Dividend per share, 12 months | – | – |
| Dividend growth a year, past | – | – |
| Buyback yield | – | – |
| Shareholder yield | – | – |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Berkshire Hathaway ($1.29T) is about 70,060.5 times Health In Tech ($18M), at today's prices.
Since November 14, 2025, BRK.A's price moved +16.2% and HIT's -79.4%. With dividends: BRK.A +16.2% (+16.2% a year), HIT -79.4% (-79.4% a year). Past returns do not predict future ones.
Neither paid a dividend over the last twelve months: Berkshire Hathaway and Health In Tech return money to shareholders, if they do, in other ways, such as buybacks.
Over the last twelve months, the net margin was 19.5% for Berkshire Hathaway and -37.1% for Health In Tech, and the operating margin – and –. Revenue was $395B and $31M.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.